Literature DB >> 1986560

Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis.

A Lambroza1, A J Dannenberg.   

Abstract

We report the case of a patient with cryptogenic cirrhosis, new onset ascites, and hyperinfection with Strongyloides stercoralis who had significant eosinophilia of the peritoneal fluid. The eosinophilia resolved with treatment of the S. stercoralis infection, and did not recur during two subsequent episodes of ascites and spontaneous bacterial peritonitis. Eosinophilic ascites is rare in parasitic infection, but it has been described in a variety of disorders which are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1986560

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model.

Authors:  Eleuza R Machado; Daniela Carlos; Carlos A Sorgi; Simone G Ramos; Daniela I Souza; Edson G Soares; Julia M Costa-Cruz; Marlene T Ueta; David M Aronoff; Lúcia H Faccioli
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

Review 2.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

3.  Strongyloidiasis presenting as eosinophilic ascites.

Authors:  S Jariwala; Y Langman; A A Benson; E Wolf; J Moss; C C Zhu; L Brandt
Journal:  Ann Trop Med Parasitol       Date:  2011-06

Review 4.  Strongyloidiasis: a conundrum for gastroenterologists.

Authors:  D I Grove
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

5.  Toxocara canis infection presenting as eosinophilic ascites and gastroenteritis.

Authors:  J L Van Laethem; F Jacobs; P Braude; A Van Gossum; J Deviere
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

Review 6.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.